These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37858848)

  • 1. Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial.
    Irfan H; Ahmed A; Nawani KD
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102144. PubMed ID: 37858848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
    Laffin LJ; Rodman D; Luther JM; Vaidya A; Weir MR; Rajicic N; Slingsby BT; Nissen SE;
    JAMA; 2023 Sep; 330(12):1140-1150. PubMed ID: 37690061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors.
    Feldman JM; Frishman WH; Aronow WS
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38358268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension.
    Awosika A; Cho Y; Bose U; Omole AE; Adabanya U
    Expert Opin Investig Drugs; 2023; 32(11):985-995. PubMed ID: 37883217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.
    Mulatero P; Groessl M; Vogt B; Schumacher C; Steele RE; Brooks A; Hossack S; Brunner HR
    Br J Clin Pharmacol; 2023 Aug; 89(8):2483-2496. PubMed ID: 36914591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.
    Calhoun DA; White WB; Krum H; Guo W; Bermann G; Trapani A; Lefkowitz MP; Ménard J
    Circulation; 2011 Nov; 124(18):1945-55. PubMed ID: 21986283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone synthase inhibition in humans.
    Azizi M; Amar L; Menard J
    Nephrol Dial Transplant; 2013 Jan; 28(1):36-43. PubMed ID: 23045428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.
    Sydorchuk L; Dzhuryak V; Sydorchuk A; Levytska S; Petrynych V; Knut R; Kshanovska A; Iftoda O; Tkachuk O; Kyfiak P; Popovich A; Khomko O; Sydorchuk R
    Endocr Regul; 2020 Jul; 54(3):217-226. PubMed ID: 32857720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension.
    Karns AD; Bral JM; Hartman D; Peppard T; Schumacher C
    J Clin Hypertens (Greenwich); 2013 Mar; 15(3):186-92. PubMed ID: 23458591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
    Freeman MW; Halvorsen YD; Marshall W; Pater M; Isaacsohn J; Pearce C; Murphy B; Alp N; Srivastava A; Bhatt DL; Brown MJ;
    N Engl J Med; 2023 Feb; 388(5):395-405. PubMed ID: 36342143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.
    Williams B; MacDonald TM; Morant SV; Webb DJ; Sever P; McInnes GT; Ford I; Cruickshank JK; Caulfield MJ; Padmanabhan S; Mackenzie IS; Salsbury J; Brown MJ;
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):464-475. PubMed ID: 29655877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST).
    Brand E; Schorr U; Ringel J; Beige J; Distler A; Sharma AM
    J Hypertens; 1999 Nov; 17(11):1563-7. PubMed ID: 10608469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population.
    Barbato A; Russo P; Siani A; Folkerd EJ; Miller MA; Venezia A; Grimaldi C; Strazzullo P; Cappuccio FP
    J Hypertens; 2004 Oct; 22(10):1895-901. PubMed ID: 15361760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
    Parthasarathy HK; Alhashmi K; McMahon AD; Struthers AD; McInnes GT; Ford I; Connell JM; MacDonald TM
    J Hypertens; 2010 Jan; 28(1):170-7. PubMed ID: 20009770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population.
    Abdel Ghafar MT
    Clin Exp Hypertens; 2019; 41(8):779-786. PubMed ID: 30561227
    [No Abstract]   [Full Text] [Related]  

  • 18. Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension.
    Dogra S; Shah S; Gitzel L; Pusukur B; Sood A; Vyas AV; Gupta R
    Curr Probl Cardiol; 2023 Nov; 48(11):101918. PubMed ID: 37399857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone synthase inhibition in hypertension.
    Andersen K
    Curr Hypertens Rep; 2013 Oct; 15(5):484-8. PubMed ID: 23917810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race, obesity, and the renin-angiotensin-aldosterone system: treatment response in children with primary hypertension.
    South AM; Arguelles L; Finer G; Langman CB
    Pediatr Nephrol; 2017 Sep; 32(9):1585-1594. PubMed ID: 28411317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.